Molecular Partners Ag MOLN Balance Sheet (2020-2026)

NASDAQ MOLN
$4.18 -0.17 (-3.76%)
As of: Sep 10, 2026 · 9:51 AM EDT
Reported Financials

Molecular Partners Ag Quarterly Balance Sheet

Periods 22 quarters
Latest Jun 2026

Molecular Partners Ag reported total assets of $95.78M and total liabilities of $21.70M for the quarter ended Jun 2026, down 36.2% year over year. This balance sheet covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
90.29M77.88M153.78M119.34M72.17M91.29M79.93M70.34M77.44M75.88M78.30M70.84M75.89M72.91M90.50M99.02M102.96M103.41M82.05M85.95M
Receivables - NetNet Receivables
6.08M27.82M3.76M19.31M1.79M1.06M1.89M20.69M2.02M2.20M3.64M20.57M3.83M2.64M4.42M4.35M2.63M2.29M2.95M1.70M
Receivables
6.08M27.82M3.76M19.31M1.79M1.06M1.89M20.69M2.02M2.20M3.64M20.57M3.83M2.64M4.42M4.35M2.63M2.29M2.95M1.70M
Prepaid Assets
8.51M6.21M4.21M5.00M4.76M3.64M4.62M3.99M4.08M3.29M3.44M3.00M2.88M2.30M2.99M2.92M2.48M2.36M2.73M
Current Assets
182.59M178.07M328.75M302.65M283.39M264.44M256.75M248.97M239.94M216.97M206.44M183.12M172.59M176.12M152.33M145.63M136.21M121.21M105.90M90.38M
Non-Current Assets
Property, Plant & Equipment (Net)
9.20M8.83M8.61M8.11M7.44M7.51M7.32M7.07M6.70M6.40M6.02M5.41M5.31M4.79M4.58M4.44M3.98M6.54M6.04M5.40M
Intangibles
0.29M0.36M0.31M0.30M0.30M0.28M0.31M0.31M0.30M0.24M0.19M0.13M0.09M0.06M0.03M0.01M0.01M0.00M0.00M
Goodwill & Intangibles
0.29M0.36M0.31M0.30M0.30M0.28M0.31M0.31M0.30M0.24M0.19M0.13M0.09M0.06M0.03M0.01M0.01M0.00M0.00M
Non-Current Assets
9.49M9.19M8.92M8.11M7.74M7.79M7.63M7.38M7.00M6.64M6.21M5.54M5.40M4.85M4.61M4.45M3.99M6.54M6.04M5.40M
Assets
192.08M187.26M337.67M310.75M291.13M272.23M264.38M256.35M246.94M223.61M212.64M188.67M177.99M180.96M156.94M150.08M140.20M127.75M111.94M95.78M
Liabilities
Current Liabilities
Accounts Payables
4.14M8.01M4.93M5.76M3.54M2.22M3.09M3.05M2.38M1.50M3.68M3.16M2.75M0.18M0.19M0.20M0.20M0.20M0.20M
Payables
4.14M8.01M4.93M5.76M3.54M2.22M3.09M3.05M2.38M1.50M3.68M3.16M2.75M0.18M0.19M0.20M0.20M0.20M0.20M
Accumulated Expenses
9.76M10.82M7.31M7.85M6.70M7.79M5.26M6.55M7.93M8.51M6.82M7.41M7.89M8.80M5.95M11.72M10.49M10.08M7.24M8.66M
Current Deferred Revenue
1.21M7.51M8.49M4.58M3.78M1.00M1.58M0.95M4.88M2.18M0.65M
Total Current Liabilities
43.22M50.83M32.95M24.21M19.72M17.91M16.63M17.43M16.46M16.25M14.07M12.56M12.04M12.31M9.97M15.58M14.68M13.80M11.24M12.42M
Non-Current Liabilities
Operating Leases
5.61M6.55M4.93M4.41M4.09M5.03M3.62M3.39M3.11M4.12M2.45M2.03M1.77M1.40M1.02M0.74M0.39M3.05M2.73M2.32M
Total Non-Current Liabilities
13.35M20.08M18.31M10.49M11.06M10.22M7.56M9.84M8.34M8.46M5.48M4.08M5.77M6.97M4.38M5.67M6.10M13.45M13.29M9.28M
Total Liabilities
56.57M70.90M51.27M34.70M30.78M28.12M24.19M27.27M24.80M24.71M19.55M16.64M17.81M19.28M14.35M21.25M20.78M27.24M24.53M21.70M
Shareholder's Equity
Common Equity
135.52M116.36M286.40M260.35M244.11M240.19M229.08M222.14M198.90M193.10M172.03M160.18M161.68M142.58M128.84M119.42M100.51M87.41M74.07M
Liabilities and Shareholders Equity
192.08M187.26M337.67M310.75M291.13M272.23M264.38M256.35M246.94M223.61M212.64M188.67M177.99M180.96M156.94M150.08M140.20M127.75M111.94M95.78M
Treasury Shares
-0.65M-0.65M
Retained Earnings
385.24M385.01M386.11M371.82M371.92M374.02M391.46M404.14M412.54M412.08M419.76M406.40M425.42M439.34M429.35M467.62M485.30M486.93M498.25M494.60M